Yahoo Web Search

Search results

    • Altimmune (NASDAQ:ALT) Lowered to Neutral at Guggenheim

      ETF DAILY NEWS· 7 days ago

      Altimmune (NASDAQ:ALT – Get Free Report) was downgraded by equities research analysts at Guggenheim from a “buy” rating to a “neutral” rating in a research note issued to investors on Monday ...